References
- Allison A.C., Byars N.E. An adjuvant formulation that selectively elicits the formulation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Meth. 1986; 95(2)157–168, [CSA]
- Alving C.R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Meth. 1991; 140: 1–13, [CROSSREF], [CSA]
- Alving C.R., Koulchin V., Glenn G.M., Rao M. Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 1995; 145: 5–31, [PUBMED], [INFOTRIEVE], [CSA]
- Alving C.R., Richards R.L. Liposomes cointaining lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol. Lett. 1990; 25: 275–280, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Antimisiaris S.G., Jayasekera P., Gregoriadis G. Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles. J. Immunol. Meth. 1993; 166: 271–280, [CROSSREF], [CSA]
- Aramaki Y., Suda H., Tsuchiya S. Interferon-γ inductive effect of liposomes as an immunoadjuvant. Vaccine 1995; 13(18)1809–1814, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Baca-Estrada M.E., Foldvari M., Snider M. Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12. J. Interferon Cytokine Res. 1999; 19: 455–462, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brynestad K., Babbit B., Huang L., Rouse B.T. Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccine. J. Virol. 1990; 64(2)680–685, [PUBMED], [INFOTRIEVE], [CSA]
- Bui T., Dykers T., Hu S.L., Faltynek C.R., Ho R.J. Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J. Acquir. Immune Defic. Syndr. 1994; 7(8)799–806, [PUBMED], [INFOTRIEVE], [CSA]
- Childers N.K., Miller K.L., Tong G., Llarena J.C., Greenway T., Ulrich J.T., Michalek S.M. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Infect. Immun. 2000; 68(10)5509–5516, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Copland M.J., Baird M.A., Rades T., McKenzie J.L., Becker B., Reck F., Tyler P.C., Davies N.M. Liposomal delivery of antigen to human dendritics cells. Vaccine 2003; 21: 883–890, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Davis D., Gregoriadis G. Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators. Immunology 1989; 68(2)277–282, [PUBMED], [INFOTRIEVE], [CSA]
- de Haan A., Geerlings H.J., Huchshorn J.P., van Scharrenburg G.J.M., Palache A.M., Wilschut J. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 1995; 13(2)55–162, [CROSSREF], [CSA]
- Foged C., Arigita C., Sundblad A., Jiskoot W., Storm G., Frokjaer S. Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine 2004; 22: 1903–1913, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fortin A., Lagace J., Therien H.M. Trafficking of surface-linked and encapsulated liposomal antigens in macrophages: an immunocytohemical study. J. Histochem. Cytohem. 2001; 49(11)1407–1420, [CSA]
- Frkanec R., Noething-Laslo V., Vranešić B., Mirosavljević K., Tomašić J. A spin labeling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes. Biochim. Biophys. Acta. 2003; 1611: 187–196, [PUBMED], [INFOTRIEVE], [CSA]
- Frkanec R., Travaš D., Krstanović M., Hallasy Špoljar B., Ljevaković Đ, Vranešić B., Frkanec L., Tomašić J. Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency. J. Liposom. Res. 2003; 13(3&4)279–294, [CROSSREF], [CSA]
- Gianan M.A.V., Kleinerman E.S. Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma patients who were at high risk for relapse: an update. Cancer Biother. Radiopharm. 1998; 13(5)363–368, [PUBMED], [INFOTRIEVE], [CSA]
- Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol. Today 1990; 11(3)89–97, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gregoriadis G., McCormack B., Obrenovic M., Perrie Y., Saffie R. Liposomes as immunological adjuvants and vaccine carriers. Vaccine Adjuvants: Preparation Methods and Research Protocols, D.T. O’Hagan. Humana Press Inc., New York, Totowa 2000; 137–150
- Gregoriadis G., Panagiotidi C. Immunodjuvant action of liposomes: comparison with other adjuvants. Immunol. Lett. 1989; 20(3)237–240, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Halassy B., Krstanović M., Frkanec R., Tomašić J. Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine 2003; 21: 971–976, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Halassy Špoljar B., Čimbora T., Hanzl-Dujmović I., Dojnović B., Sabioncello A., Krstanović M., Tomašić J. Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice. Vaccine 2002; 20: 3543–3550, [CROSSREF], [CSA]
- Harding C.V., Collins D.S., Kanagawa O., Unanue E.R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 1999; 147(9)2860–2863, [CSA]
- Hayashi A., Nakanishi T., Kunisawa J., Kondoh M., Imazu S., Tsutsumi Y., Tanaka K., Fujiwara H., Hamaoka T., Mayumi T. A novel vaccine delivery system using immunopotentating fusogenic liposomes. Biochem. Biophys. Res. Commun. 1999; 261(3)824–828, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Iinuma H., Nerome K., Yoshioka Y., Okinaga K. Characteristics of cytotoxic T-lymphocytes directed to influenza virus haemagglutinin elicited by immunization with muramyl dipeptide-influenza liposome vaccine. Scand. J. Immunol. 1995; 41: 1–10, [PUBMED], [INFOTRIEVE], [CSA]
- Keglević D., Ladešić B., Tomašić J., Valinger Z., Naumski R. Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant. Biochim Biophys Acta 1979; 585: 273–281, [CSA]
- Killion J.J., Fidler I.J. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. Pharmacol. Therap. 1998; 78(3)141–154, [CROSSREF], [CSA]
- Kim C.K., Jeong E.J., Kim M.H. Comparison of in vivo fate and immunogenicity of hepatitis B surface antigen incorporated in cationic and neutral liposomes. J. Microencap. 2000; 17(3)297–306, [CROSSREF], [CSA]
- Lian T., Ho R.J.H. Trends and developments in liposome drug delivery systems. J. Pharmac. Sci. 2001; 90(6)667–680, [CROSSREF], [CSA]
- Lipford G.B., Wagner H., Heeg K. Vaccination with immunodominant peptides encapsulated in QuilA-cointaining liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 1994; 12: 73–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ljevaković Đ, Tomašić J., Šporec V., Halassy Špoljar B., Hanzl-Dujmović I. Synthesis of novel adamantylacetyl derivate of peptidoglycan monomer-biological evaluation of immunomodulatory peptidoglycan monomer and respective derivates with lipophilic substituents on amino group. Bioorg. Med. Chem. 2000; 8: 2441–2447, [CROSSREF], [CSA]
- Maassen C.B.M., Boersma W.J.A., van Holten-Neelen C., Claassen E., Laman J.D. Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine 2003; 21: 2751–2757, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- MacEwen E.G., Kurzman I.D., Vail D.M., Dubielzig R.R., Everlith K., Madewell B.R., Rodriguez C.O., Jr., Phillips B., Zwahlen C.H., Obradovich J., Rosenthal R.C., Fox L.E., Rosenberg M., Henry C., Fidel J. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor. Clin. Cancer Res. 1999; 5: 4249–4258, [PUBMED], [INFOTRIEVE], [CSA]
- Mackova N.O., Fedoročko P. Effect of liposomal muramyl tripeptide phosphatidyl-ethanolamine and indomethacin on hematopoietic recovery in irradiated mice. Physiol. Res. 2002; 51: 511–521, [PUBMED], [INFOTRIEVE], [CSA]
- Matter H., Szilagyi L., Forgo P., Marinić Ž., Klaić B. Structure and dynamics of a peptidoglycan monomer in aqueous solution using NMR spectroscopy and stimulated annealing calculations. J. Amer. Chem. Society 1997; 119: 2212–2223, [CROSSREF], [CSA]
- Mazumdar T., Anam K., Ali N. A mixed Th1/Th2 response elicited by liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine 2004; 22: 1162–1171, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–173, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Phillips N.C., Gagne L., Ivanoff N., Riveau G. Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 1996; 14(9)898–904, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reddy R., Zhou F., Nair S., Huang L., Rouse B.T. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 1992; 148(5)1585–1589, [PUBMED], [INFOTRIEVE], [CSA]
- Serre K., Giraudo L., Henri S., Machy P., Leserman L. Dendritic cells capture and efficiently present antigen encapsulated in liposomes to T cells in vivo. J. Liposom. Res. 2003; 13(1)27–29, [CSA]
- Shek P.N., Sabiston B.H. Immune response mediated by liposome-associated protein antigens. Immunology 1982; 45: 349–356, [PUBMED], [INFOTRIEVE], [CSA]
- Sprott G.D., Dicaire C.J., Gurnani K., Sad S., Krishnan L. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis Bacillus Calmette-Guerin and adjuvant activity in vivo. Infect. Immun. 2004; 72(9)5235–5246, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stewart-Tull D.E.S. Recommendations for the assessment of adjuvants (immunopotentiators). Immunological adjuvants and Vaccines, G. Gregoriadis, A.C. Allison, G. Poste. Plenum Publishing Corporation, New York 1989; 213–226
- Tanaka Y., Kasai M., Teneichi M., Naito S., Kato H., Mori M., Nishida M., Maekawa N., Yamamura H., Komuro K., Uchida T. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages. Bioconjug. Chem. 2004; 15(1)35–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tomašić J., Hanzl-Dujmović I., Špoljar B., Vranešić B., Šantak M., Jovičić A. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse. Vaccine 2000; 18: 1236–1243, [CROSSREF], [CSA]
- Tomašić J., Hršak I. Encapsulation of immunoadjuvant (14C)peptidoglycan monomer into liposomes. Effect on metabolism and immune response in mice. Biochim. Biophys. Acta 1982; 716: 217–223, [CSA]
- Tomašić J., Sesartić Lj., Martin S.A., Valinger Z., Ladešić B. Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-l-alanine-amidase. J. Chromatog. 1988; 440: 405–414, [CROSSREF], [CSA]
- Tsujimoto M., Kotani S., Okunaga T., Kubo T., Takada H., Kubo T., Shiba T., Kusumoto S., Takahashi T., Goto Y. Enhancement of humoral immune response against viral vaccine by a non-pyrogenic 6-O-acylmuramyldipeptide and sythetic low toxicity analogues of lipid A. Vaccine 1989; 7(1)39–48, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Turanek J., Toman M., Novak J., Krchnak V., Horavova P. Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp 41. Immunol. Lett. 1994; 39(2)157–161, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ullrich S.E., Fidler I.J. Liposomes cointaining muramyl tripeptide phosphatidiylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens. J. Leukoc. Biol. 1992; 52(5)489–494, [PUBMED], [INFOTRIEVE], [CSA]
- van Rooijen N., van Nieuwmegen R. Liposomes in immunology: evidence that their adjuvant effect results from surface exposition of the antigens. Cellular Immunol. 1980; 49: 402–407, [CROSSREF], [CSA]
- van Slooten M.L., Hayon I., Babai I., Zakay-Rones Z., Wagner E., Storm G., Kedar E. Immunoadjuvant activity of interferon-γ-liposomes co-administered with influenza vaccines. Biochim. Biophys. Acta 2001; 1531: 99–110, [PUBMED], [INFOTRIEVE], [CSA]
- White W.I., Cassat D.R., Madsen J., Burke S.J., Woods R.M., Wassef N.M., Alving C.R., Koenig S. Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine 1995; 13(12)1111–1122, [PUBMED], [INFOTRIEVE], [CSA]